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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess the effect of incentives on preventing children and adolescents from starting smoking. Our review will address the following
questions:
1. Do incentives prevent children and adolescents starting smoking?
2. Does the amount and type of incentive affect prevention of starting smoking?
3. What are the cost implications to the community of incentives?
4. Are incentives more or less effective in combination with other interventions to prevent starting smoking?
5. What are the unintended consequences arising from the use of incentives e.g. false claims, ineligible applicants?
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B A C K G R O U N D
Description of the condition
Currently, 1 in 10 deaths among adults worldwide can be at-
tributed to tobacco use. This equates to more than five million
people a year, making it the leading preventable cause of death
globally (Mathers 2006). Global projections of mortality data es-
timate that unless urgent action is taken on tobacco control, this
death toll will rise to more than eight million by 2030 (Mathers
2006).
Data from the Global Youth Tobacco Survey (2000-2007) have
revealed that approximately 10% of students aged 13-15 years
smoked cigarettes, from5% in the EasternMediterrranean to 19%
in the European Region (Warren 2008). In the United States,
surveillance data from2007 found that 20%of grade 9-12 students
smoked cigarettes, with no significant difference between boys
(21%) and girls (19%) (Eaton 2008).
Adult smoking usually has its roots in adolescence. If individ-
uals do not take up smoking during this period it is unlikely
that they ever will (Mayhew 2000). Moreover, once smoking be-
comes established, cessation is challenging; the probability of sub-
sequently quitting being inversely proportional to the age of ini-
tiation (Breslau 1996). Unfortunately, most smokers initiate the
behaviour before 18 years of age; indeed among those who smoke
cigarettes, nearly 25% of young people have reported smoking
their first cigarette before the age of ten years (GYTS 2002).
Earlier onset of smoking provides for more life-years of tobacco
use, thereby increasing the associated health risks, including respi-
ratory conditions, cardiovascular disease and cancers (USDHHS
1994). Earlier onset is also associated with heavier use and heav-
ier tobacco users are less likely to quit smoking and therefore
more likely to experience tobacco-related health problems (Breslau
1996).
Given the prevalence of tobacco use among young people and the
corresponding health burden into the future, strategies to prevent
smoking in adolescence are a public health priority. Currently,
public health policies and programmes aimed at reducing tobacco
use among adolescents have demonstrated varying levels of suc-
cess. Tax increases on tobacco products are successful in reduc-
ing smoking among this target group (USDHHS 1994) and there
is some evidence for the effectiveness of mass media campaigns
(Sowden 1998). Conversely, there is limited evidence for the ef-
fectiveness of community (Sowden 2003) and school-based pro-
grammes in reducing adolescent smoking (Thomas 2006).
One novel approach to reducing the prevalence of smoking is the
use of financial incentives. While the evidence reviewed to date
has involved the use of incentives as cessation interventions among
adult smokers (Cahill 2008b,Cahill 2008a), there is growing inter-
est in the use of similar incentives schemes to encourage youngpeo-
ple to adopt healthy and pro-social behaviours (Kavanagh 2006).
A review of financial incentives programmes to improve health or
social behaviours in youth aged 11-19 years identified nine studies
which focused on healthy behaviours (Kavanagh 2006). A meta-
analysis of these studies found a statistically significant positive
impact, although the number of studies was small, as were some
of the sample sizes.
Description of the intervention
Financial incentives may take the form of contests, competitions,
incentive schemes, lotteries, raffles, and contingent payments. This
range of incentives has previously been reviewed for their effec-
tiveness for encouraging cessation and continued abstinence in
smoking cessation programmes.
A Cochrane review of ‘Quit and Win’ contests found they de-
livered quit rates above baseline community rates, however the
population impact appeared relatively low (Cahill 2008a) A sep-
arate Cochrane review of the use of competitions and incentives
for smoking cessation found no evidence for the effectiveness of
these interventions to enhance long-term abstinence from smok-
ing, with any early success usually dissipating when the reward
was no longer on offer (Cahill 2008b). The authors of both re-
views noted the lack of high quality trials limited their conclusions
and in the case of Cahill 2008b, most incentives in the included
studies were small. On the other hand, a recent study of large fi-
nancial incentives (up to $750) in employees of a multinational
company based in the United States found smoking cessation in
the incentive groups was significantly greater than in the control
group (Volpp 2009).
Financial incentives schemes have also been used for manag-
ing chronic conditions, avoiding sexually transmitted infections,
weight loss and in education (Marteau 2009). Systematic reviews
of the wider literature relating to financial incentives for encour-
aging healthy behaviours have found that incentives are effective
in stimulating ‘simple,’ discrete behavioural changes (e.g. clinic at-
tendance) (Jochelson 2007; Kane 2004). Incentives aimed at more
complex lifestyle behaviours (e.g. smoking and sexual behaviour)
are successful in increasing participation in health promotion pro-
grammes but once the incentive ceased, participants tend to re-
vert to former behaviours (Jochelson 2007). It has also been ar-
gued that the size of the incentive is important, with higher-value
incentives more powerful in encouraging behaviour change and
participation in lifestyle programmes (Jochelson 2007).
How the intervention might work
Financial incentives operate on learning theory principles by giv-
ing an immediate reward for behaviours that will provide health
gains in the future. In the field of behavioural economics, research
has found that people are motivated by the experience of past re-
wards and the prospect of future awards (Carmerer 1999). More-
over, the desire to avoid regret (i.e. not being rewarded) can be
a strong force in decision making under risk (Connolly 2006).
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Incentive schemes are also framed around what is termed “present
bias,” a tendency of humans to pursue immediate rewards ahead
of rewards that are distant but more highly valued (Volpp 2008).
Marteau et al. (Marteau 2009) notably highlight some unintended
consequences of financial incentives, including the undermining
of a participant’s intrinsic motivation (Kane 2004) and informed
consent, as well as the potential for damaging the trust between
health professionals and their patients.
Why it is important to do this review
While there is currently limited high quality evidence to sup-
port the use of financial incentive for smoking cessation, the two
Cochrane reviews performed to date only included studies which
targeted adults with the express aim of increasing quit rates. It is
conceivable that financial incentives may bemore successful with a
young audience, who may be more sensitive to monetary rewards,
and who might find it easier to not start smoking compared to the
more complex task of quitting once addicted to nicotine. While
there is promising evidence that incentives for youth might work,
currently we do no know whether financial rewards are effective
in preventing youth from starting to smoke. Given the magnitude
of the problem globally and the lack of evidence to support other
health promotion programmes in this area, this is an area worthy
of further investigation.
O B J E C T I V E S
To assess the effect of incentives on preventing children and ado-
lescents from starting smoking. Our review will address the fol-
lowing questions:
1. Do incentives prevent children and adolescents starting
smoking?
2. Does the amount and type of incentive affect prevention of
starting smoking?
3. What are the cost implications to the community of
incentives?
4. Are incentives more or less effective in combination with
other interventions to prevent starting smoking?
5. What are the unintended consequences arising from the use
of incentives e.g. false claims, ineligible applicants?
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomized controlled trials allocating individuals, groups or
communities to intervention or control conditions.
Controlled trials with baseline measures and post-intervention
outcomes.
Types of participants
Children (aged 5 to 12 years) and adolescents (aged 13 to 18)
in any setting. We will exclude trials aimed exclusively at preg-
nant women, since they are covered by the review Interventions
for promoting smoking cessation during pregnancy (Lumley 2009)
produced by the Cochrane Pregnancy and Childbirth Group.
Types of interventions
Contests, competitions, incentive schemes, lotteries, raffles, and
contingent payments to reward not starting to smoke. We will in-
clude rewards to third parties (e.g. to schools, health-care providers
or family members), as well as interventions that directly reward
children and adolescents.
For each study,wewill determinewhether the participants received
any other smoking interventions such as smoking education in
school, and whether the control group received any interventions.
Types of outcome measures
Primary outcomes
The primary outcome is the smoking status of the children or ado-
lescents who reported no smoking at baseline.We will use the out-
comes defined by the included trials, but we will prefer sustained
abstinence from smoking over point prevalence of smoking, where
both are available.We will report smoking status at the longest fol-
low up, and will require a minimum follow up of 6 months from
baseline. We will prefer but not require biochemically validated
abstinence over self report.
Secondary outcomes
We will assess the dose response of the amount of incentive. We
will also record and assess the costs, and any harms from the use
of incentives.
Search methods for identification of studies
Electronic searches
We will search the Cochrane Tobacco addiction Group Special-
ized Register, which includes studies identified by systematic elec-
tronic searches of multiple databases, and handsearching of spe-
cialist journals and the ’grey’ literature (conference proceedings
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and unpublished reports not normally covered by most electronic
databases).
In addition we will search four electronic databases, MEDLINE,
EMBASE, CINAHL and PsycINFO.
The following search terms will be used: incentive*, competition*,
contest*, lotter*, raffle*, reward*, prize*, voucher*, gift*, induce-
ment*, contingent payment*, deposit contract* in combination
with terms for smoking and tobacco use, and children and ado-
lescents.
Searching other resources
We will check cited studies while reviewing trial reports, and will
contact trial authors for any required unpublished data. We will
not apply any language restrictions.
Data collection and analysis
Selection of studies
One reviewer will prescreen all studies identified in the electronic
search. Articles will be rejected at this stage if the title and/or
abstract does not focus on the impact of financial incentives on
adolescent smoking behavior. If the article cannot be categorically
rejected by one reviewer, the full text will be obtained and screened
by two reviewers.
Two reviewers will independently assess the relevant studies for
inclusion. Discrepancies will be resolved by consensus and we will
note reasons for the non-inclusion of studies (these will appear in
the Table of Excluded Studies, with the reason for their exclusion).
The Cochrane Tobacco Addiction Group editorial team will re-
solve any ongoing disagreements between the two reviewers.
Data extraction and management
Two reviewers will independently extract the following data into
a data extraction form. At this point we will evaluate the quality
of the data:
1. Study design, including inclusion and exclusion criteria,
method of randomization (If used)
2. Setting (e.g. country, multi-centre or single centre,
inpatient or outpatient etc.)
3. Demographics of participants, including average age, sex ,
socioeconomic status, smoking status
4. Intervention and control description
5. Outcome measures, including definition of abstinence and
length of follow up, measurements used including any
biochemical verification
6. Quality of report: presence of randomization, sequence
generation, allocation concealment, blinding, intention-to-treat
analysis, drop-out rates and whether missing data are balanced
for intervention and control groups.
Assessment of risk of bias in included studies
The two reviewers will assess the risk of bias by including their
judgement in the data extraction table of the following:
1. Was the sequence generation adequate?
2. Was allocation concealed?
3. Who was blinded?
4. Were incomplete data addressed? (e.g. Was there an
intention-to-treat analysis? Was attrition greater than 20%? And
was there differential attrition between intervention and control
groups?)
5. Was the study free of selective reporting? (e.g. were all of the
study’s pre-specified outcomes reported?)
6. Was the study free of detection bias? (e.g. was there
biochemical verification of self-report smoking status?)
Measures of treatment effect
We will aim to provide a risk ratio (RR) for the outcome for each
trial, defined as (number who were smokers in the intervention
group / total number randomized to the intervention group) /
(number who were smokers in the control group / total number
randomized to the control group). . The RR will be less than 1,
and favour the intervention, if more participants abstained from
smoking in the intervention group compared to the control group.
We will calculate an estimated pooled weighted average of RRs,
using the Mantel-Haenszel fixed-effect method, with a 95% con-
fidence interval.
Unit of analysis issues
Adjusted RRs from cluster-randomized trials using schools as the
unit of analysis will be obtained either directly from those trials
that report adjusted results or by adjusting the original (non-ad-
justed) risk ratios using an intraclass correlation coefficient (ICC)
of 0.097 (the ICC for current smoking status averaged among all
ethnicities reported by Siddiqui et al. (Siddiqui 1996)). This will
allow for the pooling of both cluster- and individually randomized
trials. Adjusted RRs from cluster-randomized trials using group-
ings other than schools (e.g. neighbourhoods) as the unit of anal-
ysis will be obtained either directly from those trials that report
adjusted results or by adjusting the original (non-adjusted) risk
ratios using an appropriate intraclass correlation coefficient (ICC)
for that grouping or, if that is not available, analysed separately.
Dealing with missing data
Where possible we will contact the trial authors to request missing
data. We will exclude participants for whom no outcome data is
available, rather than conducting an intention-to-treat analysis of
all randomized participants with imputed values for the missing
data (Higgins 2008).
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Assessment of heterogeneity
The method of synthesising the studies will depend on the type,
quality, design and heterogeneity of the included studies. We will
consider pooling the data in the event that no significant hetero-
geneity between the studies is demonstrated.Wewill use the x² test
and the I² statistic to assess statistical heterogeneity. An I² value
of greater than 50% may be considered to represent substantial
heterogeneity (Higgins 2008).
Assessment of reporting biases
If there are at least 10 studies included in themeta-analysis, we will
prepare a funnel plot to investigate for the possibility of reporting
biases.
Subgroup analysis and investigation of heterogeneity
If there is substantial heterogeneity present, wewill explore the rea-
sons for this, whichmay include undertaking subgroup analyses (if
there are sufficient studies to do this). Possible subgroup analyses
may include: by type of intervention (solely financial rewards ver-
sus financial rewards plus other smoking cessation intervention;
staged versus one-off incentive); type of incentive (individual ver-
sus rewards to third parties; lottery versus definite payment of a
specified reward amount); size of the incentive (low, high).
Sensitivity analysis
We will test study design in a sensitivity analysis by first including,
then excluding less rigorous trials (e.g. quasi-randomized trials).
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